These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27017053)

  • 1. Treatment of canine non-indolent T cell lymphoma using the VELCAP-TSC protocol: A retrospective evaluation of 70 dogs (2003-2013).
    Goodman IH; Moore AS; Frimberger AE
    Vet J; 2016 May; 211():39-44. PubMed ID: 27017053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics and prognostic factors for canine multicentric non-indolent T-cell lymphoma: 107 cases.
    Purzycka K; Peters LM; Desmas I; Davies O; Chang YM; Lara-Garcia A
    Vet Comp Oncol; 2020 Dec; 18(4):656-663. PubMed ID: 32163214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
    Blaxill J; Buzzacott P; Finlay J
    Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
    Morgan E; O'Connell K; Thomson M; Griffin A
    Vet Comp Oncol; 2018 Dec; 16(4):622-629. PubMed ID: 30117253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.
    Siedlecki CT; Kass PH; Jakubiak MJ; Dank G; Lyons J; Kent MS
    Can Vet J; 2006 Jan; 47(1):52-9. PubMed ID: 16536229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of T cell lymphoma in dogs.
    Moore AS
    Vet Rec; 2016 Sep; 179(11):277. PubMed ID: 27634860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.
    Brown PM; Tzannes S; Nguyen S; White J; Langova V
    Vet Comp Oncol; 2018 Mar; 16(1):108-113. PubMed ID: 28508557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma.
    Lucas SR; Maranhão RC; Guerra JL; Coelho BM; Barboza R; Pozzi DH
    Vet Comp Oncol; 2015 Sep; 13(3):184-93. PubMed ID: 23615221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
    Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
    J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of the updated Kiel classification in canine high-grade T-cell lymphomas.
    Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
    Vet Med Sci; 2024 Jul; 10(4):e1398. PubMed ID: 38767567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation.
    Aresu L; Martini V; Rossi F; Vignoli M; Sampaolo M; Aricò A; Laganga P; Pierini A; Frayssinet P; Mantovani R; Marconato L
    Vet Comp Oncol; 2015 Dec; 13(4):348-62. PubMed ID: 23782432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
    Curran K; Thamm DH
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():147-55. PubMed ID: 26279153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
    Back AR; Schleis SE; Smrkovski OA; Lee J; Smith AN; Phillips JC
    Vet Comp Oncol; 2015 Dec; 13(4):398-408. PubMed ID: 23910023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.
    Davies O; Szladovits B; Polton G; Garden OA; Leo C; Lara-Garcia A
    Vet Comp Oncol; 2018 Jun; 16(2):276-287. PubMed ID: 29271043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparaginase and MOPP treatment of dogs with lymphoma.
    Brodsky EM; Maudlin GN; Lachowicz JL; Post GS
    J Vet Intern Med; 2009; 23(3):578-84. PubMed ID: 19645842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Vet J; 2015 Jul; 205(1):69-73. PubMed ID: 26004824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma.
    Al-Nadaf S; Rebhun RB; Curran KM; Venable RO; Skorupski KA; Willcox JL; Burton JH
    BMC Vet Res; 2018 Nov; 14(1):356. PubMed ID: 30458771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.
    Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB
    J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma.
    Limmer S; Nerschbach V; Eberle N; Teske E; Simon Betz D
    Acta Vet Scand; 2022 Dec; 64(1):36. PubMed ID: 36503518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.